Authors:
HASHIMOTO O
UENO T
SATA M
UCHIMURA Y
TANIKAWA K
Citation: O. Hashimoto et al., LONG-TERM IMPROVEMENT OF HEPATIC-FIBROSIS IN CHRONIC HEPATITIS-C TREATED WITH INTERFERON-ALPHA, Hepatology research, 10(3), 1998, pp. 200-216
Authors:
SUJAKU K
UENO T
TORIMURA T
SATA M
TANIKAWA K
Citation: K. Sujaku et al., EFFECTS OF OK-432 ON MATRIX METALLOPROTEINASE-9 EXPRESSION AND ACTIVITY IN RAT CULTURED KUPFFER CELLS, Hepatology research, 10(2), 1998, pp. 91-100
Authors:
SATA M
NOGUCHI S
IDE T
SUZUKI H
KUMASHIRO R
NAGAO Y
KAGE M
SAITSU H
KUROHIJI T
TANIKAWA K
Citation: M. Sata et al., LACK OF DETECTION OF HEPATITIS-C VIRUS REPLICATIVE INTERMEDIATE IN ABDOMINAL LYMPH-NODES, Hepatology research, 10(1), 1998, pp. 66-73
Citation: M. Sata et K. Walsh, TNF-ALPHA REGULATION OF FAS LIGAND EXPRESSION ON THE VASCULAR ENDOTHELIUM MODULATES LEUKOCYTE EXTRAVASATION, Nature medicine, 4(4), 1998, pp. 415-420
Authors:
MIYAJIMA I
SATA M
KUMASHIRO R
UCHIMURA Y
IDE T
SUZUKI H
TANIKAWA K
Citation: I. Miyajima et al., THE INCIDENCE OF HEPATOCELLULAR-CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS-C AFTER INTERFERON TREATMENT, Oncology Reports, 5(1), 1998, pp. 201-204
Authors:
TANAKA K
SATA M
UCHIMURA Y
SUZUKI H
TANIKAWA K
Citation: K. Tanaka et al., LONG-TERM EVALUATION OF INTERFERON THERAPY IN HEPATITIS-C VIRUS-ASSOCIATED CIRRHOSIS - DOES IFN PREVENT DEVELOPMENT OF HEPATOCELLULAR-CARCINOMA, Oncology Reports, 5(1), 1998, pp. 205-208
Authors:
TSURUTA O
KAWANO H
FUJITA M
TSUJI Y
MIYAZAKI S
FUJISAKI K
WATANABE M
NAKAHARA K
TATEISHI H
BAN S
IKEDA H
TAKEDA T
SATA M
TOYONAGA A
Citation: O. Tsuruta et al., USEFULNESS OF THE HIGH-FREQUENCY ULTRASOUND PROBE IN PRETHERAPEUTIC STAGING OF SUPERFICIAL-TYPE COLORECTAL TUMORS, International journal of oncology, 13(4), 1998, pp. 677-684
Authors:
UENO T
HASHIMOTO O
SUGAWARA H
OGATA R
KUSABA N
TORIMURA T
SATA M
TANIKAWA K
Citation: T. Ueno et al., SERUM CARBOXY-TERMINAL CROSS-LINKED TELOPEPTIDE OF TYPE-I COLLAGEN REFLECTS BONE METASTASIS IN HEPATOCELLULAR-CARCINOMA, International journal of oncology, 13(2), 1998, pp. 297-303
Authors:
YAMASHITA F
TANAKA M
FUKUMORI K
ANDO E
YANO Y
KATO O
YAMAMOTO H
FUKUDA H
KUSABA T
TANIKAWA K
SATA M
Citation: F. Yamashita et al., A CROSSOVER STUDY OF ORAL-ADMINISTRATION OF UFT IN CHRONIC LIVER-DISEASE - COMPARISON OF CONTINUOUS AND INTERMITTENT SCHEDULES, Anti-cancer drugs, 9(5), 1998, pp. 399-404
Authors:
SATA M
NAKANO H
SUZUKI H
NOGUCHI S
YAMAKAWA Y
TANAKA E
FUKUIZUMI K
TANAKA K
YOSHIDA H
TANIKAWA K
Citation: M. Sata et al., SEROEPIDEMIOLOGIC STUDY OF HEPATITIS-C VIRUS-INFECTION IN FUKUOKA, JAPAN, Journal of gastroenterology, 33(2), 1998, pp. 218-222
Authors:
KOMUTA M
HARADA M
UENO T
UCHIMURA Y
INADA C
MITSUYAMA K
SAKISAKA S
SATA M
TANIKAWA K
Citation: M. Komuta et al., UNUSUAL ACCUMULATION OF GLYCOGEN IN LIVER PARENCHYMAL-CELLS IN A PATIENT WITH ANOREXIA-NERVOSA, Internal medicine, 37(8), 1998, pp. 678-682
Citation: M. Sata et K. Walsh, REGULATED EXPRESSION OF FAS LIGAND ON ENDOTHELIUM MODULATES LEUKOCYTEINFILTRATION OF THE BLOOD-VESSEL WALL, Journal of the American College of Cardiology, 31(2), 1998, pp. 3-3
Authors:
HARADA M
MITSUYAMA K
YOSHIDA H
SAKISAKA S
TANIGUCHI E
KAWAGUCHI T
ARIYOSHI M
SAIKI T
SAKAMOTO M
NAGATA K
SATA M
MATSUO K
TANIKAWA K
Citation: M. Harada et al., VASCULAR ENDOTHELIAL GROWTH-FACTOR IN PATIENTS WITH RHEUMATOID-ARTHRITIS, Scandinavian journal of rheumatology, 27(5), 1998, pp. 377-380
Authors:
HARADA M
YOSHIDA H
MITSUYAMA K
SAKAMOTO M
KOGA H
MATSUO K
TESHIMA Y
IKEDA E
SAKISAKA S
SATA M
TANIKAWA K
Citation: M. Harada et al., AORTITIS SYNDROME (TAKAYASUS-ARTERITIS) WITH CATARACT AND ELEVATED SERUM LEVEL OF VASCULAR ENDOTHELIAL GROWTH-FACTOR, Scandinavian journal of rheumatology, 27(1), 1998, pp. 78-79
Authors:
TANIGUCHI E
SAKISAKA S
KOGA H
KAWAGUCHI T
OHISHI M
SASATOMI K
HARADA M
SATA M
Citation: E. Taniguchi et al., EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR IN HEPATOCYTES OF REGENERATING RAT-LIVER, Hepatology, 28(4), 1998, pp. 67-67
Authors:
UENO T
TAMAKI S
TORIMURA T
KUSABA N
SAKAMOTO M
OGATA R
KIM K
INUZUKA S
SATA M
TANIKAWA K
Citation: T. Ueno et al., AN ENDOTHELIN RECEPTOR ANTAGONIST IMPROVES PORTAL-HYPERTENSION AND HEPATIC BLOOD-FLOW IN EXPERIMENTAL CIRRHOTIC RATS, Hepatology, 28(4), 1998, pp. 119-119
Authors:
TANAKA M
ANDO E
YAMASHITA F
SHIMAUCHI Y
KUROMATSU R
SAKISAKA S
TANIKAWA K
SATA M
Citation: M. Tanaka et al., SIGNIFICANCE OF FATTY CHANGE IN EARLY HEPATOCELLULAR-CARCINOMA AS A MORPHOLOGIC TUMOR-MARKER AND ITS DEVELOPMENTAL MECHANISM, Hepatology, 28(4), 1998, pp. 265-265
Authors:
TANAKA M
ANDO E
YAMASHITA F
SHIMAUCHI Y
KUROMATSU R
SAKISAKA S
TANIKAWA K
SATA M
Citation: M. Tanaka et al., HEPATIC ARTERIAL INFUSION CHEMOTHERAPY USING 5-FU AND CDDP IN ADVANCED HEPATOCELLULAR-CARCINOMA INVOLVING PORTAL-VEIN TUMOR THROMBUS, Hepatology, 28(4), 1998, pp. 266-266